Vaccine for Staph More Lethal Than Skin Cancer Tested

A new wave of experimental vaccines is the medical community’s latest hope against a powerful staph infection that kills more people in the U.S. than skin cancer and costs as much as $8 billion a year to treat.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.